The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2013
|
| In: |
Haematologica, the hematology journal
Year: 2013, Volume: 98, Issue: 5, Pages: 714-717 |
| ISSN: | 1592-8721 |
| Online Access: | Verlag, kostenfrei, Volltext: http://www.haematologica.org/content/98/5/714
|
| Author Notes: | Lange, Thoralf ... Mueller, Martin C. ... |
| Item Description: | Gesehen am: 18.12.2014 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1592-8721 |